BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 23832679)

  • 21. Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma.
    Ai Z; Pan H; Suo T; Lv C; Wang Y; Tong S; Liu H
    Cancer Lett; 2011 Nov; 310(2):181-7. PubMed ID: 21788103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
    Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
    Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
    Kim MJ; Kim RK; Yoon CH; An S; Hwang SG; Suh Y; Park MJ; Chung HY; Kim IG; Lee SJ
    J Cell Sci; 2011 Sep; 124(Pt 18):3084-94. PubMed ID: 21878493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.
    Saito N; Aoki K; Hirai N; Fujita S; Iwama J; Hiramoto Y; Ishii M; Sato K; Nakayama H; Harashina J; Hayashi M; Izukura H; Kimura H; Ito K; Sakurai T; Yokouchi Y; Oharazeki T; Takahashi K; Iwabuchi S
    Brain Tumor Pathol; 2015 Jul; 32(3):176-83. PubMed ID: 25665548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of CD200 expression in glioma cells enhances microglia activation and tumor growth.
    Wang CY; Hsieh YT; Fang KM; Yang CS; Tzeng SF
    J Neurosci Res; 2016 Dec; 94(12):1460-1471. PubMed ID: 27629530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
    Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
    World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
    Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells.
    Uchida H; Arita K; Yunoue S; Yonezawa H; Shinsato Y; Kawano H; Hirano H; Hanaya R; Tokimura H
    J Neurooncol; 2011 Sep; 104(3):697-704. PubMed ID: 21380601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
    Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
    Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells.
    Wei Y; Jiang Y; Zou F; Liu Y; Wang S; Xu N; Xu W; Cui C; Xing Y; Liu Y; Cao B; Liu C; Wu G; Ao H; Zhang X; Jiang J
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6829-34. PubMed ID: 23569237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
    Xiao Z; Yang X; Liu Z; Shao Z; Song C; Zhang K; Wang X; Li Z
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.
    Zhao N; Guo Y; Zhang M; Lin L; Zheng Z
    Oncol Rep; 2010 May; 23(5):1443-7. PubMed ID: 20372862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.
    Purow BW; Haque RM; Noel MW; Su Q; Burdick MJ; Lee J; Sundaresan T; Pastorino S; Park JK; Mikolaenko I; Maric D; Eberhart CG; Fine HA
    Cancer Res; 2005 Mar; 65(6):2353-63. PubMed ID: 15781650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy using Notch and Akt inhibitors is effective for suppressing invasion but not proliferation in glioma cells.
    Jin R; Nakada M; Teng L; Furuta T; Sabit H; Hayashi Y; Demuth T; Hirao A; Sato H; Zhao G; Hamada J
    Neurosci Lett; 2013 Feb; 534():316-21. PubMed ID: 23262078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
    PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.